A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)

IRB/UVA Tracking #
21338
Contact
Maria Davenport
Contact Email
Contact Phone
1.434.297.4110
Phase
II
Primary purpose
Screening
Cancer PI
Ryan Gentzler
Status
OPEN TO ACCRUAL
Ages
Adult